The role of HHV-8 in Kaposi's sarcoma

Seminars in Cancer Biology

Volumn 9, Issue 3, 1999, Pages 151-164

  Neipel, Frank ^a   Fleckenstein, Bernhard ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Cytokines; HHV 8; Kaposi's sarcoma; KSHV; Oncogenes; Pathogenesis

Indexed keywords

ANGIOGENIC FACTOR; CYTOKINE; VIRUS DNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL CULTURE; EUROPE; HUMAN; HUMAN HERPESVIRUS 8; KAPOSI SARCOMA; NONHUMAN; NORTH AMERICA; REVIEW; SEROCONVERSION; SPINDLE CELL; VIRUS CARCINOGENESIS; VIRUS GENE;

EID: 0033047874     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1006/scbi.1999.0129     Document Type: Article

References (82)

1. Friedman Kien AE, Laubenstein LJ, Rubinstein P, Buimovici Klein E, Marmor M, Stahl R, Spigland I, Kim KS, Zolla Pazner S. Disseminated Kaposi's sarcoma in homosexual men. Ann Intern Med. 96:1982;693-700.
2. Beral, V, Peterman, TA, Berkelman, RL, Jaffe, HW, 1990, 123, 128.
3. Beral V, Bull D, Darby S, Weller I, Carne C, Beecham M, Jaffe H. Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS. Lancet. 339:1992;632-635.
4. Siegal B, Levinton Kriss S, Schiffer A, Sayar J, Engelberg I, Vonsover A, Ramon YR-E. Kaposi's sarcoma in immunosuppression. Possibly the result of a dual viral infection. Cancer. 65:1990;492-498.
5. Kempf W, Adams V, Hassam S, Schmid M, Moos R, Briner J, Pfaltz M. [Detection of human herpesvirus type 6, human herpesvirus type 7, cytomegalovirus and human papillomavirus in cutaneous AIDS-associated Kaposi's sarcoma]. Verh Dtsch Ges Pathol. 78:1994;260-264.
6. Adams V, Kempf W, Hassam S, Briner J, Schmid M, Moos R, Pfaltz M. Detection of several types of human papilloma viruses in AIDS-associated Kaposi's sarcoma. J Med Virol. 46:1995;189-193.
7. Monini P, Rotola A, de Lellis L, Corallini A, Secchiero P, Albini A, Benelli R, Parravicini C, Barbanti Brodano G, Cassai E. Latent BK virus infection and Kaposi's sarcoma pathogenesis. Int J Cancer. 66:1996;717-722.
8. Lifson, AR, Darrow, WW, Hessol, NA, O'Malley, PM, Barnhart, L, Jaffe, HW, R, utherford, GW, 1990.
9. Kempf W, Adams V, Pfaltz M, Briner J, Schmid M, Moos R, Hassam S. Human herpesvirus type 6 and cytomegalovirus in AIDS-associated Kaposi's sarcoma: no evidence for an etiological association. Hum Pathol. 26:1995;914-919.
10. +cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B. Proc Natl Acad Sci USA. 94:1997;7600-7605.
11. Lisitsyn NA, Lisitsyn NM, Wigler M. Cloning the differences betw een to complex genomes. Science. 259:1993;946-951.
12. Chang Y, Cesarman E, Pessin MS, Lee F, Culpepper J, Knowles DM, Moore PS. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science. 266:1994;1865-1869.
13. Neipel, F, Albrecht, JC, Ensser, A, Huang, YQ, Li, JJ, Friedman, Kien, AE, Fleckenstein, B, 1997.
14. Cesarman E, Chang Y, Moore PS, Said JW, Knowles DM. Kaposi's sar coma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med. 332:1995;1186-1191.
15. Rabkin CS, Schulz TF, Whitby D, Lennette ET, Magpantay LI, Chatlynne L, Biggar RJ. Interassay correlation of human herpesvirus 8 serologic tests. HHV-8 Interlaboratory Collaborative Group. J Infect Dis. 178:1998;304-309.
16. Gao SJ, Kingsley L, Li M, Zheng W, Parravicini C, Ziegler J, Newton R, Rinaldo CR, Saah A, Phair J, Detels R, Chang Y, Moore PS. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med. 2:1996;925-928.
17. Kedes DH, Ganem D, Ameli N, Bacchetti P, Greenblatt R. The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women. J Am Med Assoc. 277:1997;478-481.
18. Miller G, Rigsby MO, Heston L, Grogan E, Sun R, Metroka C, Levy JA, Gao SJC-Y, Moore P. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus inpatients with HIV-1 infection. N Engl J Med. 334:1996;1292-1297.
19. Simpson GR, Schulz TF, Whitby D, Cook PM, Boshoff C, Rainbow L, Howard MR, Gao SJ, Bohenzky RA, Simmonds P, Lee C, de Ruiter A, Hatzakis A, Tedder RS, Weller IVD, Weiss RA, Moore PS. Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen. Lancet. 348:1996;1133-1138.
20. Raab MS, Albrecht JC, Birkmann A, Yaguboglu S, Lang D, Fleckenstein B, Neipel F. The immunogenic glycoprotein gp35-37 of human herpesvirus 8 is encoded by open reading frame K8.1. J Virol. 72:1998;6725-6731.
21. Martin JN, Ganem DE, Osmond DH, Page-Shafer KA, Macrae D, Kedes DH. Sexual transmission and the natural history of human herpesvirus 8 infection. N Engl J Med. 338:1998;948-954.
22. Ariyoshi K, Schim van der Loeff M, Cook P, Whitby D, Corrah T, Jaffar S, Cham F, Sabally S, O'Donovan D, Weiss RA, Schulz TF, Whittle H. Kaposi's sarcoma in the Gambia, West Africa, is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol. 1:1998;193-199.
23. Russo JJ, Bohenzky RA, Chen MC, Chen J, Yan M, Maddalena D, Parry JP, Peruzzi D, Edelman IS, Chang Y, Moore PS. Nucleotide sequence of the Kaposi's sarcoma-accociated herpesvirus (HHV-8). Proc Natl Acad Sci USA. 93:1996;14862.
24. Lee H, Veazey R, Williams K, Li M, Guo J, Neipel F, Fleckenstein B, La ckner A, Desrosiers RC, Jung JU. Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med. 4:1998;435-440.
25. Lee H, Guo J, Li M, Choi JK, DeMaria M, Rosenzweig M, Jung JU. Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol. 18:1998;5219-5228.
26. Fujita T, Sakakibara J, Sudo Y, Miyamoto M, Kimura Y, Taniguchi T. Evidence for a nuclear factor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J. 7:1988;3397-3405.
27. Itoh S, Harada H, Fujita T, Mimura T, Taniguchi T. Sequence of a cDNA coding for human IRF-2. Nucleic Acids Res. 17:1989;8372.
28. Lin R, Mustafa A, Nguyen H, Gewert D, Hiscott J. Mutational analysis of interferon (IFN) regulatory factors 1 and 2. Effects on the induction of IFN-β gene expression. J Biol Chem. 269:1994;17542-17549.
29. Nguyen H, Mustafa A, Hiscott J, Lin R. Transcription factor IRF-2 exerts its oncogenic phenotype through the DNA binding/transcription repression domain. Oncogene. 11:1995;537-544.
30. Gao SJ, Kingsley L, Hoover DR, Spira TJ, Rinaldo CR, Saah A, Phair J, Detels RP-P, Chang Y, Moore PS. Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med. 335:1996;233-241.
31. Li M, Lee H, Guo J, Neipel F, Fleckenstein B, Ozato K, Jung JU. Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol. 72:1998;5433-5440.
32. Zimring JC, Goodbourn S, Offermann MK. Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. J Virol. 72:1998;701-707.
33. Arvanitakis L, Geras Raaka E, Varma A, Gershengorn MC, Cesarman E. Human herpesvirus KSHV encodes a constitutively active G-protein-coupled receptor linked to cell proliferation. Nature. 385:1997;347-350.
34. Bais C, Santomasso B, Coso O, Arvanitakis L, Raaka EG, Gutkind JS, Asch AS, Cesarman E, Gerhengorn MC, Mesri EA. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature. 391:1998;86-89.
35. Li M, Lee H, Yoon D-W, Albrecht JC, Fleckenstein B, Neipel F, Jung JU. Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol. 71:1997;1984-1991.
36. Godden-Kent D, Talbot SJ, Boshoff C, Chang Y, Moore P, Weiss RA, Mittnacht S. The cyclin encoded by Kaposi's sarcoma-associated herpesvirus stimulates cdk6 to phosphorylate the retinoblastoma protein and histone H1. J Virol. 71:1997;4193-4198.
37. Swanton C, Mann QJ, Fleckenstein B, Neipel F, Peters G, Jones N. Herpes viral cyclin/cdk6 complexes evade inhibition by cdk inhibitor proteins. Nature. 390:1997;184-187.
38. Ellis M, Chew YP, Fallis L, Freddersdorf S, Boshoff C, Weiss RA, Lu X, Mittnacht S. Degradation of p27(Kip) cdk inhibitor triggered by Kaposi's sarcoma virus cyclin-cdk6 complex. EMBO J. 18:1999;644-653.
39. Mann DJ, Child ES, Swanton C, Laman H, Jones N. Modulation of p27(Kip1) levels by the cyclin encoded by Kaposl's sarcoma-associated herpesvirus. EMBO J. 18:1999;654-663.
40. Pines J. Cyclins, CDKs and cancer. Semin Cancer Biol. 6:1995;63-72.
41. Muralidhar S, Pumfery AM, Hassani M, Sadaie MR, Azumi N, Kishishita M, Brady JN, Doniger J, Medveczky P, Rosenthal LJ. Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol. 72:1998;4980-4988.
42. Lebbe C, Blum L, Pellet C, Blanchard G, Verola O, Morel P, Danne O, Calvo F. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS. 12:1998.
43. Delabesse E, Oksenhendler E, Lebbe C, Verola O, Varet B, Turhan AG. Molecular analysis of clonality in Kaposi's sarcoma. J Clin Pathol. 50:1997;664-668.
44. Gill P, Tsai Y, Rao AP, Jones P. Clonality in Kaposi's sarcoma [letter; comment]. N Engl J Med. 337:1997;570-571.
45. Rabkin CS, Janz S, Lash A, Coleman AE, Musaba E, Liotta L, Biggar RJ, Zhuang Z. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N Engl J Med. 336:1997;988-993.
46. Gill PS, Tsai YC, Rao AP, Spruck CH, Zheng T, Harrington WAJ, Cheung T, Nathwani B, Jones PA. Evidence for multiclonality in multicentric Kaposi's sarcoma. Proc Natl Acad Sci USA. 95:1998;8257-8261.
47. Ruszczak Z, Mayer-Da S, Orfanos CE. Angioproliferative changes i n clinically non-involved, perilesional skin in AIDS-associated Kaposi's sarcoma. Dermatologica. 175:1987;270-279.
48. Ruszczak Z, Mayer-Da SA, Orfanos CE. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early skin lesions. Am J Dermatopathol. 9:1987;388-398.
49. +T cells. Science. 242:1988;426-430.
50. Salahuddin SZ, Nakamura S, Biberfeld P, Kaplan MH, Markham PD, Larsson L, Gallo RC. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science. 242:1988;430-433.
51. Ensoli B, Stürzl M. Kaposi's sarcoma: a result of the interpl ay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:1998;63-83.
52. Samaniego F, Markham PD, Gendelman R, Watanabe Y, Kao V, Kowalski K, Sonnabend JA, Pintus A, Gallo RC, Ensoli B. Vascular endotelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development. Am J Pathol. 152:1998;1433-1443.
53. Neipel F, Albrecht JC, Ensser A, Huang YQ, Li JJ, Friedman Kien AE, Fleckenstein B. Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol. 71:1997;839-842.
54. Moore PS, Boshoff C, Weiss RA, Chang Y. Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science. 274:1996;1739-1744.
55. Nicholas J, Ruvolo VR, Burns WH, Sandford G, Wan X, Ciufo D, Hendrickson SB, Guo HG, Hayward GS, Reitz MS. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med. 3:1997;287-292.
56. Molden J, Chang Y, You Y, Moore PS, Goldsmith MA. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J Biol Chem. 272:1997;19625-19631.
57. Burger R, Neipel F, Fleckenstein B, Savino R, Ciliberto G, Kalden JR, Gramatzki M. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood. 91:1998;1858-1863.
58. Miles SA, Martinez Maza O, Rezai A, Magpantay L, Kishimoto T, Nakamura S, Radka SF, Linsley PS. Onco- statin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science. 255:1992;1432-1434.
59. Masood R, Lunardi Iskandar Y, Jean LF, Murphy JR, Waters C, Gallo RC, Gill P. Inhibition of AIDS-associated Kaposi's sarcoma cell growth by DAB389-interleukin 6. AIDS Res Hum Retroviruses. 10:1994;969-975.
60. Murakami Mori K, Taga T, Kishimoto T, Nakamura S. AIDS-associate d Kaposi's sarcoma (KS) cells express onco- statin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies. J Clin Invest. 96:1995;1319-1327.
61. Peters M, Muller AM, Rose-John S. Interleukin-6 and soluble inte rleukin-6 reccptor: direct stimulation of gp130 and hematopoiesis. Blood. 92:1998;3495-3504.
62. Fischer M, Goldschmitt J, Peschel C, Brakenhoff JP, Kallen KJ, Wollmer A, Grotzinger J, Rose-John S. 1. A bioactive designer cytokine for human hematopoietic progenitor cell expansion. Nat Biotechnol. 15:1997;142-145.
63. Boshoff C, Endo Y, Collins PD, Takeuchi Y, Reeves JD, Schweickart VL, Siani MA, Sasaki T, Williams TJ, Gray PW, Moore PS, Chang Y, Weiss RA. Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science. 278:1997;290-294.
64. Jussila L, Valtola R, Partanen TA, Salven P, Heikkila P, Matikainen MT, Renkonen R, Kaipainen A, Detmar M, Tschachler E, Alitalo R, Alitalo K. Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res. 58:1998;1599-1604.
65. Boshoff C, Schulz TF, Kennedy MM, Graham AK, Fisher C, Thomas A, McGee JO, Weiss RA, O'Leary JJ. Kaposi's sarcoma-associated herpesvirus infects endothelial and spindle cells. Nat Med. 1:1995;1274-1278.
66. Kennedy MM, Cooper K, Howells DD, Picton S, Biddolph S, Lucas SB, McGee JO, O'Leary JJ. Identification of HHV8 in early Kaposi's sarcoma: implications for Kaposi's sarcoma pathogenesis. Mol Pathol. 51:1998;14-20.
67. Ganem, D, 1997, 157, 160.
68. Blasig C, Zietz C, Haar B, Neipel F, Esser S, Brockmeyer NH, Tschachler E, Colombini S, Ensoli B, Stürzl M. Monocytes in Kaposi's sarcoma lesions are productively infected by human herpesvirus 8. J Virol. 71:1997;7963-7968.
69. Staskus KA, Zhong W, Gebhard K, Herndier B, Wang H, Renne R, Beneke J, Pudney J, Anderson DJ, Ganem D, Haase AT. Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol. 71:1997;715-719.
70. Lagunoff M, Ganem D. The structure and coding organization of th e genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology. 236:1997;147-154.
71. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, Ganem D. A c luster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol. 72:1998;8309-8315.
72. Sarid R, Flore O, Bohenzky RA, Chang Y, Moore PS. Transcription mapping of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) genome in a body cavity-based lymphoma cell line (BC-1). J Virol. 72:1998;1005-1012.
73. Sarid R, Wiezorek JS, Moore PS, Chang Y. Characterization and cell cycle regulation of the major Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) latent genes and their promoter. J Virol. 73:1999;1438-1446.
74. Sun R, Lin SF, Staskus K, Gradoville L, Grogan E, Haase A, Miller G. Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression. J Virol. 73:1999;2232-2242.
75. Stürzl M, Blasig C, Schreier A, Neipel F, Hohenadl C, Cornali E, Ascherl G, Esser S, Brockmeyer NH, Ekman M, Kaaya EE, Tschachler E, Biberfeld P. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma. Int J Cancer. 72:1997;68-71.
76. Davis MA, Stürzl M, Blasig C, Schreier A, Guo HG, Reitz M, Opalenik SR, Browning PJ. Expression of human herpesvirus 8-encoded cyclin D in Kaposi's sarcoma spindle cells. J Natl Cancer Inst. 89:1997;1868-1874.
77. Renne R, Zhong W, Herndier B, McGrath MS, Abbey N, Kedes DH, Ganem DE. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nature Med. 2:1996;342-346.
78. Miller G, Heston L, Grogan E, Gradoville L, Rigsby M, Sun R, Shedd D, Kushnaryov VM, Grossberg S, Chang Y. Selective switch between latency and lytic replication of Kaposi's sarcoma herpesvirus and Epstein-Barr virus in dually infected body cavity lymphoma cells. J Virol. 71:1997;314-324.
79. Rainbow L, Platt GM, Simpson GR, Sarid R, Gao SJ, Stoiber H, Herrington CS, Moore PS, Schulz TF. The 222-234-kDa latent nuclear protein (LNA) of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) is encoded by orf73 and is a component of the latency-associated nuclear antigen. J Virol. 71:1997;5915-5921.
80. Kellam, P, Boshoff C, Whitby D, Matthews S, Weiss RA, Talbot SJ. Identification of a major latent nuclear antigen, LNA-1, in the human herpesvirus 8 genome. J Hum Virol. 1:1997;19-29.
81. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J. Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature. 386:1997;517-521.
82. Albrecht JC, Nicholas J, Biller D, Cameron KR, Biesinger B, Newman C, Wittmann S, Craxton MA, Coleman H, Fleckenstein B, Honess RW. Primary structure of the herpesvirus saimiri genome. J Virol. 66:1992;5047-5058.